Antidepressant-Like Effects of Low- and High-Molecular Weight FGF-2 on Chronic Unpredictable Mild Stress Mice

The occurrence of depressive disorder has long been attributed to changes in monoamines, with the focus of drug treatment strategies being to change the effectiveness of monoamines. However, the success achieved by changing these processes is limited and further stimulates the exploration of alterna...

Full description

Bibliographic Details
Main Authors: Lin Wang, Xi-Xi Li, Xi Chen, Xiao-Yan Qin, Elissavet Kardami, Yong Cheng
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-10-01
Series:Frontiers in Molecular Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fnmol.2018.00377/full
_version_ 1811344891522842624
author Lin Wang
Xi-Xi Li
Xi Chen
Xiao-Yan Qin
Elissavet Kardami
Yong Cheng
author_facet Lin Wang
Xi-Xi Li
Xi Chen
Xiao-Yan Qin
Elissavet Kardami
Yong Cheng
author_sort Lin Wang
collection DOAJ
description The occurrence of depressive disorder has long been attributed to changes in monoamines, with the focus of drug treatment strategies being to change the effectiveness of monoamines. However, the success achieved by changing these processes is limited and further stimulates the exploration of alternative mechanisms and treatments. Fibroblast growth factor 2 (FGF-2), which occurs in a high-molecular weight (HMW) and low-molecular weight (LMW) form, is a potent developmental modulator and nervous system regulator that has been suggested to play an important role in various psychiatric disorders. In this study, we investigated the antidepressant effects of HMW and LMW FGF-2 on depression induced by chronic stress. Both peripheral LMW and HMW FGF-2 attenuated the depression-like behaviors in chronic unpredictable mild stress (CUMS) mice to a similar extent, as determined by the forced swimming, tail suspension, and sucrose preference tests. We then showed that CUMS-induced oxidative stresses in mice were inhibited by FGF-2 treatments both in central and peripheral. We also showed that both forms of FGF-2 increased the phosphorylation of ERK and AKT, increased Bcl-2 expression and inhibited caspase-3 activation in CUMS mice. Interestingly, HMW FGF-2 enhanced the activity of the brain-derived neurotrophic factor (BDNF) to a greater extent than did LMW FGF-2 in the hippocampus. Taken together, these results suggest that depressive symptoms can be relieved by administering different forms of FGF-2 peripherally in a CUMS-induced depression model through a similar antidepressant signaling pathway, therefore suggesting a potential clinical use for FGF-2 as a treatment for depression.
first_indexed 2024-04-13T19:54:55Z
format Article
id doaj.art-bb16da0bc4d6453baacb779726f586b7
institution Directory Open Access Journal
issn 1662-5099
language English
last_indexed 2024-04-13T19:54:55Z
publishDate 2018-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Molecular Neuroscience
spelling doaj.art-bb16da0bc4d6453baacb779726f586b72022-12-22T02:32:22ZengFrontiers Media S.A.Frontiers in Molecular Neuroscience1662-50992018-10-011110.3389/fnmol.2018.00377399982Antidepressant-Like Effects of Low- and High-Molecular Weight FGF-2 on Chronic Unpredictable Mild Stress MiceLin Wang0Xi-Xi Li1Xi Chen2Xiao-Yan Qin3Elissavet Kardami4Yong Cheng5Key Laboratory of Ethnomedicine for Ministry of Education, Center on Translational Neuroscience, College of Life and Environmental Sciences, Minzu University of China, Beijing, ChinaKey Laboratory of Ethnomedicine for Ministry of Education, Center on Translational Neuroscience, College of Life and Environmental Sciences, Minzu University of China, Beijing, ChinaSchool of Pharmacy, Minzu University of China, Beijing, ChinaKey Laboratory of Ethnomedicine for Ministry of Education, Center on Translational Neuroscience, College of Life and Environmental Sciences, Minzu University of China, Beijing, ChinaInstitute of Cardiovascular Sciences, St. Boniface Hospital Albrechtsen Research Centre, University of Manitoba, Winnipeg, MB, CanadaKey Laboratory of Ethnomedicine for Ministry of Education, Center on Translational Neuroscience, College of Life and Environmental Sciences, Minzu University of China, Beijing, ChinaThe occurrence of depressive disorder has long been attributed to changes in monoamines, with the focus of drug treatment strategies being to change the effectiveness of monoamines. However, the success achieved by changing these processes is limited and further stimulates the exploration of alternative mechanisms and treatments. Fibroblast growth factor 2 (FGF-2), which occurs in a high-molecular weight (HMW) and low-molecular weight (LMW) form, is a potent developmental modulator and nervous system regulator that has been suggested to play an important role in various psychiatric disorders. In this study, we investigated the antidepressant effects of HMW and LMW FGF-2 on depression induced by chronic stress. Both peripheral LMW and HMW FGF-2 attenuated the depression-like behaviors in chronic unpredictable mild stress (CUMS) mice to a similar extent, as determined by the forced swimming, tail suspension, and sucrose preference tests. We then showed that CUMS-induced oxidative stresses in mice were inhibited by FGF-2 treatments both in central and peripheral. We also showed that both forms of FGF-2 increased the phosphorylation of ERK and AKT, increased Bcl-2 expression and inhibited caspase-3 activation in CUMS mice. Interestingly, HMW FGF-2 enhanced the activity of the brain-derived neurotrophic factor (BDNF) to a greater extent than did LMW FGF-2 in the hippocampus. Taken together, these results suggest that depressive symptoms can be relieved by administering different forms of FGF-2 peripherally in a CUMS-induced depression model through a similar antidepressant signaling pathway, therefore suggesting a potential clinical use for FGF-2 as a treatment for depression.https://www.frontiersin.org/article/10.3389/fnmol.2018.00377/fullHMW FGF-2LMW FGF-2depressionoxidative stressAKTERK
spellingShingle Lin Wang
Xi-Xi Li
Xi Chen
Xiao-Yan Qin
Elissavet Kardami
Yong Cheng
Antidepressant-Like Effects of Low- and High-Molecular Weight FGF-2 on Chronic Unpredictable Mild Stress Mice
Frontiers in Molecular Neuroscience
HMW FGF-2
LMW FGF-2
depression
oxidative stress
AKT
ERK
title Antidepressant-Like Effects of Low- and High-Molecular Weight FGF-2 on Chronic Unpredictable Mild Stress Mice
title_full Antidepressant-Like Effects of Low- and High-Molecular Weight FGF-2 on Chronic Unpredictable Mild Stress Mice
title_fullStr Antidepressant-Like Effects of Low- and High-Molecular Weight FGF-2 on Chronic Unpredictable Mild Stress Mice
title_full_unstemmed Antidepressant-Like Effects of Low- and High-Molecular Weight FGF-2 on Chronic Unpredictable Mild Stress Mice
title_short Antidepressant-Like Effects of Low- and High-Molecular Weight FGF-2 on Chronic Unpredictable Mild Stress Mice
title_sort antidepressant like effects of low and high molecular weight fgf 2 on chronic unpredictable mild stress mice
topic HMW FGF-2
LMW FGF-2
depression
oxidative stress
AKT
ERK
url https://www.frontiersin.org/article/10.3389/fnmol.2018.00377/full
work_keys_str_mv AT linwang antidepressantlikeeffectsoflowandhighmolecularweightfgf2onchronicunpredictablemildstressmice
AT xixili antidepressantlikeeffectsoflowandhighmolecularweightfgf2onchronicunpredictablemildstressmice
AT xichen antidepressantlikeeffectsoflowandhighmolecularweightfgf2onchronicunpredictablemildstressmice
AT xiaoyanqin antidepressantlikeeffectsoflowandhighmolecularweightfgf2onchronicunpredictablemildstressmice
AT elissavetkardami antidepressantlikeeffectsoflowandhighmolecularweightfgf2onchronicunpredictablemildstressmice
AT yongcheng antidepressantlikeeffectsoflowandhighmolecularweightfgf2onchronicunpredictablemildstressmice